Sulfated fucoidan FP08S2 inhibits lung cancer cell growth in vivo by disrupting angiogenesis via targeting VEGFR2/VEGF
Disrupted VEGF–VEGFR2 binding, reducing angiogenesis and tumor growth in A549 xenografts.
Lung Cancer
Lung Cancer
Lung Cancer
Fucoidan from seaweed Fucus vesiculosus inhibits migration and invasion of human lung cancer cell via PI3K-Akt-mTOR pathways
Inhibition of lung cancer cell growth and metastasis via modulation of PI3K-Akt-mTOR pathways.
Lung Cancer
Fucoidan inhibition of lung cancer in vivo and in vitro : role of the Smurf2-dependent ubiquitin proteasome pathway in TGFβ receptor degradation
Research on the role of Smurf2-dependent ubiquitin proteasome pathway in TGFβ receptor degradation.
Antitumor effect and molecular mechanism of fucoidan in NSCLC
Fucoidan represents an ideal therapeutic agent for non-small cell lung cancer (NSCLC).
Lung Cancer
Fucoidan enhances the effect of chemotherapeutic drug against drug-resistant lung cancer cells
Synergy with chemotherapy for drug-resistant lung cancer cells.